Baricitinib Therapy in COVID-19
Clinical trial NCT04358614 · COMPLETED
Trial details
- NCT number
- NCT04358614
- Sponsor
- Fabrizio Cantini
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2020-04-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.